AbbVie Foundation
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$217,738,010
Investments
73%
Cash & Equivalents
27%
Receivables (Non-Related)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$60,372,725
Grants Payable
94%
Other Liabilities
4%
Payables & Accruals
2%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Tax-Exempt Bond Liabilities
N/A
Custodial & Escrow Liabilities
N/A
Assets
2023
2024
Change
Cash & Equivalents
$46,983,200
$59,000,666
+26%
Receivables (Non-Related)
$0
$406,130
-
Related-Party Receivables
$0
$0
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
$420,920
$158,331,214
+37516%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
$0
$0
-
Total Assets
$47,404,120
$217,738,010
+359%
Liabilities
2023
2024
Change
Payables & Accruals
$61,308
$1,500,000
+2347%
Grants Payable
-
$56,677,772
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
N/A
N/A
N/A
Custodial & Escrow Liabilities
N/A
N/A
N/A
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$1,999,930
$2,194,953
+10%
Total Liabilities
$2,061,238
$60,372,725
+2829%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$45,342,882
$157,365,285
+247%
Net assets
2023
2024
Change
Net assets
+$45,342,882
+$157,365,285
+247%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)